Brief: Oncology Institute Q4 revenue USD 71 million
09/03/2023 21:20
Mar 9 (Reuters) - Oncology Institute Q4 net income USD -9.5 million. * Q4 gross profit USD 16 million * Q4 revenue USD 71 million
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million